Field Medical, founded in 2022 and based in Cardiff-by-the-Sea, California, is developing the FieldForce pulsed field ablation system to treat ventricular tachycardia. It raised a $35 million Series B in July 2025, taking total funding to $75 million.
At a glance
| Price from | Custom |
| Best for | Electrophysiologists treating ventricular tachycardia |
From Field Medical's own website.
What stands out
- FDA Breakthrough Device designation
- Targets a hard-to-treat arrhythmia
Worth knowing
- Pivotal trial still under way
- Not approved for sale
How it ranks
Field Medical is ranked 10th of 10 in Best Medtech Startups (Lister Score 85.3).
#10 in Best Medtech Startups · Lister Score 85.3
FieldForce received FDA Breakthrough Device designation in December 2024..
| Rank | Best Medtech Startups | Score |
|---|---|---|
| 1 | Neuralink | 97.0 |
| 2 | Neko Health | 95.7 |
| 3 | Precision Neuroscience | 94.4 |
| 4 | Science Corp | 93.1 |
| 5 | Synchron | 91.8 |
| 6 | Medical Microinstruments (MMI) | 90.5 |
| 7 | ForSight Robotics | 89.2 |
| 8 | Noah Medical | 87.9 |
| 9 | Capstan Medical | 86.6 |
| 10 | Field Medical | 85.3 |
Frequently asked questions
How does Field Medical rank on Lister?
Field Medical is ranked 10th of 10 in Best Medtech Startups (Lister Score 85.3).
Appears in
Add this badge to your site
If you work at Field Medical, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.